Profile data is unavailable for this security.
About the company
Cisen Pharmaceutical Co., Ltd is a China-based company principally involved in the research, development, manufacturing and sales of medical products. The Company operates through two main segments. The Main Business segment is primarily involved in the manufacturing and sales of medicine, among which include infusion, freeze-dried powder, small volume injection, tablet, capsules, ointment, drops and active pharmaceutical ingredients, among others. The Other Business segment is mainly involved in the sales of raw materials and houses tenancy.
- Revenue in CNY (TTM)4.25bn
- Net income in CNY529.01m
- Incorporated1998
- Employees3.40k
- LocationCisen Pharmaceutical Co LtdNo.16 Tongji Road, Hi-tech ZoneJINING 272073ChinaCHN
- Phone+86 5 372989906
- Fax+86 5 372215851
- Websitehttp://www.cisen-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chengdu Easton Biopharmaceuticals Co Ltd | 1.31bn | 249.88m | 6.20bn | 1.40k | 24.59 | 2.31 | -- | 4.74 | 1.43 | 1.43 | 7.47 | 15.16 | 0.3941 | 1.83 | 6.97 | 933,769.90 | 7.53 | 8.72 | 9.23 | 10.64 | 75.76 | 85.10 | 19.11 | 19.16 | 2.65 | -- | 0.0717 | 26.80 | -4.56 | 7.76 | -8.09 | 10.91 | 17.99 | -- |
| Cisen Pharmaceutical Co Ltd | 4.25bn | 529.01m | 6.45bn | 3.40k | 12.18 | 1.11 | -- | 1.52 | 1.17 | 1.17 | 9.41 | 12.89 | 0.585 | 2.15 | 6.06 | 1,250,659.00 | 7.33 | 6.94 | 9.10 | 8.56 | 57.72 | 56.27 | 12.53 | 10.77 | 2.63 | -- | 0.0329 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
| Jianmin Pharmaceutical Group Co Ltd | 3.98bn | 427.95m | 6.70bn | 2.50k | 15.61 | 2.80 | -- | 1.68 | 2.80 | 2.80 | 25.98 | 15.61 | 0.9793 | 6.99 | 4.16 | 1,592,652.00 | 10.62 | 10.87 | 18.49 | 19.11 | 42.34 | 43.04 | 10.84 | 9.32 | 1.38 | -- | 0.1492 | 37.15 | 15.72 | 14.28 | 27.78 | 45.05 | 8.77 | 43.10 |
| Sichuan Huiyu Pharmaceutical Co Ltd | 1.12bn | 278.20m | 6.82bn | 1.36k | 24.52 | 1.76 | -- | 6.09 | 0.6567 | 0.6567 | 2.64 | 9.16 | 0.2335 | 1.18 | 21.25 | 820,954.90 | 5.66 | 10.41 | 7.08 | 12.76 | 83.40 | 89.89 | 24.23 | 21.42 | 2.57 | -- | 0.1488 | 20.54 | -37.92 | 76.37 | -43.86 | -- | 66.72 | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 691.62m | 105.20m | 6.90bn | 948.00 | 85.74 | 3.77 | -- | 9.97 | 0.0998 | 0.0998 | 0.6509 | 2.27 | 0.2482 | 1.53 | 1.50 | 729,558.10 | 3.76 | 7.03 | 4.43 | 9.05 | 90.24 | 92.17 | 15.15 | 17.26 | 6.06 | -- | 0.0048 | 26.31 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
| Wuhan Keqian Biology Co Ltd | 902.14m | 299.11m | 6.92bn | 923.00 | 23.19 | 1.79 | -- | 7.67 | 0.6404 | 0.6404 | 1.93 | 8.28 | 0.1968 | 2.44 | 2.47 | 977,402.10 | 6.51 | 13.29 | 7.62 | 15.49 | 63.87 | 76.49 | 33.08 | 45.71 | 4.71 | -- | 0.0209 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
Data as of Nov 05 2024. Currency figures normalised to Cisen Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 7.70m | 1.71% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2024 | 1.29m | 0.29% |
| Purekind Fund Management Co., Ltd.as of 30 Jun 2024 | 866.10k | 0.19% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 788.90k | 0.18% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 673.10k | 0.15% |
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2024 | 600.00k | 0.13% |
| Acadian Asset Management LLCas of 30 Sep 2024 | 379.31k | 0.08% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2024 | 345.00k | 0.08% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 265.30k | 0.06% |
| Dongxing Asset Management Co. Ltd.as of 30 Jun 2024 | 251.50k | 0.06% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
